A skin marker for geriatric cancer.
Dermatomyositis must be differentiated from a number of other diseases, including lupus erythematosus, myxedema, and contact dermatitis. Mixed connective-tissue disease also may be seen as a proximal myopathy and has similar skin findings. Satisfactory treatment of the underlying malignancy often results in disappearance or easier control of the dermatomyositis. The initial treatment step, however, is high-dose corticosteroids combined with oral immunosuppressives to control muscular and cutaneous inflammation.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000368:Aged; D003882:Dermatomyositis / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy / Q000503:physiopathology; D003937:Diagnosis, Differential; D004576:Electromyography; D005853:Geriatrics; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000175:diagnosis / Q000503:physiopathology; D009369:Neoplasms / Q000150:complications / Q000175:diagnosis*; D011038:Rothmund-Thomson Syndrome / Q000473:pathology
D000305:Adrenal Cortex Hormones